Theratechnologies to Present at the B. Riley Securities Virtual Oncology Investor Conference
Theratechnologies (NASDAQ: THTX) announced that CEO Paul Levesque and CMO Dr. Christian Marsolais will present at the B. Riley Virtual Oncology Investor Conference on January 20, 2021, at 3:30 p.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Theratechnologies (NASDAQ: THTX) announced that CEO Paul Levesque and CMO Dr. Christian Marsolais will present at the B. Riley Virtual Oncology Investor Conference on January 20, 2021, at 3:30 p.m. ET. The presentation will focus on the company's innovative therapies aimed at addressing unmet medical needs. Interested parties can access the live virtual presentation through the company's website's 'News' section, with a replay available two hours later. For more information, visit theratech.com.
Details
News Market Reaction – THTX
The recorded move for THTX in the trading session of this news was +0.78%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MONTREAL, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Paul Levesque, President and Chief Executive Officer and Dr. Christian Marsolais, Senior Vice President and Chief Medical Officer will present at the B. Riley Virtual Oncology Investor Conference on Wednesday, January 20, 2021 at 3:30 p.m. ET.
To access the live virtual presentation, please visit the ‘News’ section of the Company’s website. A webcast replay will also be available approximately two hours after the presentation.
About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.
For media inquiries:
Denis Boucher
Vice-President, Communications and Corporate Affairs
514-336-7800
For investor inquiries:
Leah Gibson
Senior Director, Investor Relations
lgibson@theratech.com
617-356-1009
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.